Copernicus Capital Management’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-135,946
Closed -$3.32M 16
2019
Q1
$3.32M Buy
135,946
+42,946
+46% +$1.05M 8.52% 4
2018
Q4
$2.41M Buy
93,000
+50,178
+117% +$1.3M 4.54% 11
2018
Q3
$1.36M Sell
42,822
-101,560
-70% -$3.21M 1.27% 16
2018
Q2
$5.61M Buy
144,382
+36,382
+34% +$1.41M 4.07% 12
2018
Q1
$2.98M Buy
+108,000
New +$2.98M 2.38% 18